trending Market Intelligence /marketintelligence/en/news-insights/trending/YNB63KDbgwcKOHsD3glPag2 content esgSubNav
In This List

IBio to raise $5M in common stock, warrants offering


Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection


Japan M&A By the Numbers: Q4 2023


Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

IBio to raise $5M in common stock, warrants offering

IBio Inc. has priced an underwritten public offering of common stock and warrants to raise about $5 million in gross proceeds.

New York-based iBio is selling a total of 45,100,000 shares in the offering, through either common shares or warrants to purchase shares. The underwriters have been granted an option to purchase an additional 3,750,000 common shares, or 7,500,000 common warrants.

Shares in the offering will be sold at 20 cents apiece, with warrants exercised at 22 cents.

The company did not disclose how the proceeds will be used.

A.G.P./Alliance Global Partners is serving as book-running manager for the offering.

IBio is a plant-based biopharmaceutical contract development company that creates biologics for research and other manufacturing uses.